A case report of surgical resection treatment for complete remission after chemotherapy for advanced pancreatic cancer

Author:

Zhang Zhongyan,Lin Hongfeng,Li Hehe,Wang Xin

Abstract

Pancreatic cancer is a common type of cancer that is treated using surgery or chemotherapy. However, for patients who cannot have surgery, the treatment options are limited and have a low success rate. We report a case of a patient with locally advanced pancreatic cancer who was unable to have surgery due to a tumor that had invaded the coeliac axis and portal vein. However, after receiving chemotherapy with gemcitabine plus nab-paclitaxel(GEM-NabP), the patient achieved complete remission, and a PET-CT scan confirmed that the tumor had disappeared. Eventually, the patient underwent radical surgery with distal pancreatectomy with splenectomy, and the treatment was successful. This case is rare, and there are few reports of complete remission after chemotherapy for pancreatic cancer. This article reviews the relevant literature and guides future clinical practice

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference11 articles.

1. Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: a retrospective study;He Yong-Gang;World J Gastrointest Oncol,2022

2. Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation;Paiella;Transl Gastroenterol Hepatol,2018

3. A locally advanced pancreatic body cancer presenting common bile duct invasion resected via distal pancreatectomy after gemcitabine plus nab-paclitaxel chemotherapy: a case report;Kawasaki Hiroshi;Int J Surg Case Rep,2022

4. A long-term survival case of locally advanced unresectable pancreatic adenocarcinoma after chemoradiotherapy and conversion surgery;Ohmura Yoshiaki;Gan To Kagaku Ryoho,2021

5. Neoadjuvant therapy for pancreatic cancer;Springfeld;Nat Rev Clin Oncol,2023

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3